Press release
Global Influenza Vaccines Market worth USD 4.34 Billion in 2021-GMI Research
global influenza vaccines market (2016-2021)
The report on “Influenza Vaccines Market by Vaccine Type (Quadrivalent, Trivalent), by Route of Administration (Intramuscular, Intravenous, Others), and by Geography – Global Forecasts to 2021”. The global influenza vaccines market has been estimated to be worth USD 4.65 Billion in 2016 and is projected to be valued at USD 8.81 Billion by the end of 2021, registering a CAGR of 13.6% during forecast period. Increasing pandemic outbreak, growing geriatric population, and rising affordability of flu vaccines in emerging economies are the key factors bolstering the growth of the influenza vaccines market.
Based on Vaccine Type, Quadrivalent Vaccines is projected to be the fastest growing segment
The specificity as well as the effectiveness of quadrivalent influenza vaccines and increasing consumer demand for quadrivalent flu vaccines are the key factors propelling the growth of quadrivalent flu vaccines market. Quadrivalent flu vaccines provides protection against four strains of influenza viruses. These include Quadrivalent flu shots which are used diverse age groups. Intradermal Quadrivalent flu shot and Quadrivalent flu shot are the two major types having virus grown in cell culture. The growing baby boomer population is also an important factor which will fuel the growth of the said market during the forecast period.
Get Sample PDF Report Brochure: https://www.gmiresearch.com/sample-research-report.php?rid=56
Based on Route of Administration, Intramuscular flu vaccines segment is estimated to hold the largest market share in the influenza vaccines market
The intramuscular flu vaccines segment is estimated to capture the largest share of the total influenza vaccines market due to the increased demand for these vaccines globally. There has been increasing participation of countries to get vaccinated intramuscularly to avoid side effects and complications associated with other routes of administration.
Asia-Pacific is expected to witness a substantial growth in the influenza vaccines market during the forecast period
The high demand for seasonal and pandemic influenza vaccines in Asia-Pacific countries (for example India, China, Japan, Australia etc.) primarily prompted during influenza A/H1N1 (swine flu) pandemic. Also, with the strong demand for domestic flu vaccines and the government's stepped-up support, the development and production of flu vaccines is poised to be a new growth area for emerging countries drug makers, especially major companies with larger production capacity. The influenza vaccines market is expected to register further growth in the emerging economies such as India and China.
The report further profiles the major companies active in this field, including Sanofi, GlaxoSmithKline plc, CSL Ltd, AstraZeneca, Sarepta Therapeutics, Inc., Inovio Pharmaceuticals, Inc., Abbott, Janssen Global Services, LLC amongst others.
Browse Press Release: https://www.gmiresearch.com/press-release-description.php?descid=6
The global Influenza Vaccines market is segmented based on geography:
Global Influenza Vaccines Market by Vaccine Type
•Quadrivalent
•Trivalent
Global Influenza Vaccines Market by Route of Administration
•Intramuscular
•Intravenous
•Others
Global Influenza Vaccines Market by Region
•North America
•Europe
•Asia-Pacific
•RoW
Global Influenza Vaccines Market by Country
•U.S.
•U.K.
•India
•China
•Brazil
Global Influenza Vaccines Market Competitive Landscape
•Major Players and their Market Share Analysis
•New product launches
•Mergers and acquisitions, Collaborations, partnerships, agreements and Joint ventures
Buy Report Here: https://www.gmiresearch.com/report/influenza-vaccines-market-vaccine-type-quadrivalent-trivalent.html
About GMI Research
GMI Research is a market research and consulting firm which provides research-based solutions to business executives and investment professionals so that they can make right business & investment decisions faster based on real facts. We help business leaders through independent fact-based insight, ensuring their business achieve success by beating the competition.
GMI Research leverages its industry expertise and experience to identify the industry trends, big opportunities and potential growth areas across industries. Our Syndicated reports provide actionable insights and covers industry trends, market drivers & restraints, macroeconomic factors, market estimates & forecasts, competitive landscape etc. which helps our clients to strengthen its market position by deploying specific strategies and actions that will lead to higher growth.
Our Customized Research (Market Intelligence and Competitive Intelligence) Offerings
Our clients rely on us for the range of our services to give them the intelligence they need to act decisively. GMI Research offers in-depth market and competitive intelligence solutions by leveraging its industry knowledge and experience to provide accurate insights with a complete picture of the market and competition. To know more about our product offering click on the below link
https://www.gmiresearch.com/productservices/marketcompetitiveintelligence.html
Our Knowledge Services Solutions
GMI Research provides offshore market and competitive intelligence research services to companies worldwide. We leverage our industry knowledge and research expertise gained through various research studies conducted across verticals which enables us to deliver high-level quality support to our clients. By engaging us, our clients can achieve substantial cost reductions by outsourcing non-core functions. As a result, it allows our clients to improve their productivity while managing their in-house resources intelligently.
https://www.gmiresearch.com/productservices/knowledgeprocessoutsourcing.html
Contact Sales Department:
Anuradha Sarangi
Tel: +353 1 442 8820
Email: sales@gmiresearch.com
GMI Research is a market research and consulting firm which provides research-based solutions to business executives and investment professionals so that they can make right business & investment decisions faster based on real facts. We help business leaders through independent fact-based insight, ensuring their business achieve success by beating the competition.
Level 1, The Chase Carmanhall Road,
Sandyford Industrial Estate,
Dublin D18 Y3X2, Ireland
+353 1 442 8820
sales@gmiresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Influenza Vaccines Market worth USD 4.34 Billion in 2021-GMI Research here
News-ID: 775091 • Views: …
More Releases from GMI Research
OLED Market is projected to rise at a higher CAGR during the forecast period | S …
The OLED Market is anticipated to expand at a remarkable CAGR during the forecast period
For Additional Insights, Click to Access Complete Report -
https://www.gmiresearch.com/report/global-oled-market/
The factors driving growth of the OLED Market includes increasing penetration of smartphones and gaming consoles around the world, Government policies supporting OLED lighting research, growing popularity of smart Televisions and improvements in the living standards. For instance, the revenue generated from the sales of video game consoles…
3D Printed Drugs Market is growing at a CAGR of 4.2% over the forecast period | …
The 3D Printed Drugs Market is growing at a CAGR of 4.2% over the forecast period.
For Additional Insights, Click to Access Complete Report - https://www.gmiresearch.com/report/global-3d-printed-drugs-market-by-technique-type/
The factors driving growth of the 3D Printed Drugs Market includes increasing geriatric population around the world, growing demand for soluble drugs, rising prevalence of stroke, Alzheimer's disease and head and neck tumors and improvements in the living standards. For instance, the population aged 60 and…
Virtual Private Cloud Market is expected to grow at a higher CAGR of 23.4% over …
The Virtual Private Cloud Market is projected to grow at a CAGR of 23.4% over the forecast period.
For Additional Insights, Click to Access Complete Report - https://www.gmiresearch.com/report/global-virtual-private-cloud-market/
The factors driving growth of the Virtual Private Cloud Market includes huge volumes of data generated across BSFI, Healthcare and Media & Entertainment industries, rising focus by companies on modernizing IT infrastructure, Government initiatives promoting digitalization, increasing number of data breaches reported around the…
Pest Control Services Market is poised to grow at a robust CAGR during the forec …
The Pest Control Services Market is estimated to grow at a robust CAGR over the forecast period
For Additional Insights, Click to Access Complete Report -
https://www.gmiresearch.com/report/pest-control-services-market/
The factors driving growth of market includes increasing demand for pest control services from hospitality, pharmaceutical, and food processing industries, growing focus on using biocides, rising concerns related to climate change, and improvements in the living standards. For instance, the market value of biocides worldwide was…
More Releases for Vaccine
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market…
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market.
Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top…
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze…
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Measles Vaccine Market Production and Demand Analysis 2019 to 2025
Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025
Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Measles Vaccine Market to Insight By 2025: Top Key Vendors
The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the…
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016.
Paediatric vaccine market is a billion dollar market accounting for a substantial proportion…
Key Tools for Innovative Vaccine Designs: Vaccine Adjuvants
The report “NORTH AMERICA VACCINE ADJUVANTS MARKET” provides the detail description of market segmentation, applications, growth, size, and outlook. The market is projected to reach USD $278 Million by 2024, at a CAGR of 11.3%.
An adjuvant is an immunological agent, which modifies the effect of other agents. Adjuvants can also act as an irritant, which engages and amplifies the body immune response. Adjuvants are added to vaccines to boost the…
